Showing results (71-80 of 424) with videos related to

Sort By:
Pageof 43
The Oncologist|July 25, 2019
Artificial Intelligence Systems Assisting Oncologists? Resist and Desist or Enlist and CoexistJacob J Adashek, Ishwaria M Subbiah, Vivek Subbiah
Frontiers in Medicine|December 2, 2022
Current and future targeted alpha particle therapies for osteosarcoma: Radium-223, actinium-225, and thorium-227Peter M Anderson, Vivek Subbiah, Matteo M Trucco
NPJ Precision Oncology|October 9, 2025
Prolonged response to dual immune checkpoint blockade in patients with advanced solid tumors: a case seriesCamila B Xavier, Mohamed A Gouda, Apostolia M Tsimberidou
Cancers|October 16, 2024
Tissue-Agnostic Targeting of Neurotrophic Tyrosine Receptor Kinase Fusions: Current Approvals and Future DirectionsMohamed A Gouda, Kyaw Z Thein, David S Hong
Diagnostics (Basel, Switzerland)|February 18, 2017
Defining Clinical Response Criteria and Early Response Criteria for Precision Oncology: Current State-of-the-Art and Future PerspectivesVivek Subbiah, Hubert H Chuang, Dhiraj Gambhire, et al.
Journal of Medical Case Reports|November 27, 2007
Tissue is the issue-sarcoidosis following ABVD chemotherapy for Hodgkin's lymphoma: a case reportVivek Subbiah, Uyen K Ly, Amer Khiyami, et al.
JCO Precision Oncology|September 11, 2020
Precision Oncology in Sarcomas: Divide and ConquerRoberto Carmagnani Pestana, Roman Groisberg, Jason Roszik, et al.
Diagnostics (Basel, Switzerland)|September 14, 2024
Assessing the Effectiveness of Selective RET Inhibitors in RET-Positive Cancers through Fluorodeoxyglucose Uptake AnalysisKalevi Kairemo, Homer A Macapinlac, Mohammed Gouda, et al.
JCO Precision Oncology|April 3, 2026
Living Guidelines for Tumor-Agnostic Therapies: A Pathway to Next-Generation Cancer TreatmentVivek Subbiah, Thomas K Oliver, Jim Palma, et al.
Diagnostics (Basel, Switzerland)|April 5, 2017
An Assessment of Early Response to Targeted Therapy via Molecular Imaging: A Pilot Study of 3'-deoxy-3'[(18)F]-Fluorothymidine Positron Emission Tomography 18F-FLT PET/CT in Prostate AdenocarcinomaKalevi Kairemo, Gregory C Ravizzini, Homer A Macapinlac, et al.
Pageof 43